Vaughn Usher v. Nipro Diabetes Systems, Inc., and Nipro Medical Corporation

184 So. 3d 1260, 2016 WL 717917
CourtDistrict Court of Appeal of Florida
DecidedFebruary 24, 2016
Docket4D14-4766
StatusPublished
Cited by7 cases

This text of 184 So. 3d 1260 (Vaughn Usher v. Nipro Diabetes Systems, Inc., and Nipro Medical Corporation) is published on Counsel Stack Legal Research, covering District Court of Appeal of Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Vaughn Usher v. Nipro Diabetes Systems, Inc., and Nipro Medical Corporation, 184 So. 3d 1260, 2016 WL 717917 (Fla. Ct. App. 2016).

Opinions

PER CURIAM.

We reverse the order dismissing Vaughn Usher’s various complaints with prejudice for failure to state causes of action. The pleadings attempted to state claims under Florida’s whistleblower act and for age discrimination under Florida’s Civil Rights Act of 1992.

Section 448.102(3), Florida Statutes (2009) precludes an employer from taking “any retaliatory personnel action against an employee because the employee has objected to, or refused to participate in, any activity, policy, or practice of the employer which is in violation of a law, rule, or regulation.” “ ‘Law, rule, or regulation’ includes any statute or ordinance or any rule or regulation adopted pursuant to any federal, state, or local statute-or ordinance applicable to the employer and pertaining to the business.” § 448.101(4), Fla. Stat. (2009).

To state a claim under the statute, Usher was required to plead “ ‘1) that [ ]he objected to or refused to participate in any [1262]*1262illegal activity, policy or practice of [Ni-pro]; -2)[]he suffered an adverse employment action; and 3) the adverse employment action was causally linked to h[is] objection, or refusal.’” Aery v. Wallace Lincoln-Mercury, LLC, 118 So.3d 904, 915 (Fla. 4th DCA 2013) (quoting Gleason v. Roche Labs., Inc., 745 F.Supp.2d 1262, 1270 (M.D.Fla.2010)); see also Rivera v. Torfino Enters., Inc., 914 So.2d 1087, 1089 (Fla. 4th DCA 2005).

Usher’s complaint pleaded violations of • sections of the Federal Food, Drug, and Cosmetic Act with respect to the insulin pump appellee manufactured. Usher further' alleged that “documentation and testing was out of compliance with FDA requirements” 'and that all the products for sale were illegal “because documentation was ‘bogus’ in that the testing was not done as prescribed and the testing protocols were not properly validated.” His complaint cited relevant portions of the United States Code ,and the Code of Federal Regulations, Combined with allegations of the adverse employment action and the causal connection between Usher’s objections the adverse employment action, the complaint sufficiently stated a cause of action under the whistleblower statute.

We also find that Usher stated a claim under section 760.10(1)(a), Florida Statutes (2009). He pleaded that he was over 40 years of age, that at 54 he was appellee’s oldest engineer at the time of termination, that new hires were generally 10-20 years younger, and that he was qualified to do the job for which he was rejected. See, e.g., Kragor v. Takeda Pharm. Am., Inc., 702 F.3d 1304, 1308 (11th Cir.2012). He pleaded that, several months before his termination, his boss told him, “I don’t want any of those slow old guys around here any more.”

Reversed and remanded.

WARNER and LEVINE, JJ., concur.. GROSS, J., concurs specially with opinion.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Gessner v. Southern Company and Gulf Power Company
District Court of Appeal of Florida, 2024
LE PUBLICATIONS, INC. v. RANDALL KOHL
District Court of Appeal of Florida, 2020
Lin v. Demings
219 So. 3d 124 (District Court of Appeal of Florida, 2017)
Graddy v. Wal-Mart Stores East, LP
237 F. Supp. 3d 1223 (M.D. Florida, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
184 So. 3d 1260, 2016 WL 717917, Counsel Stack Legal Research, https://law.counselstack.com/opinion/vaughn-usher-v-nipro-diabetes-systems-inc-and-nipro-medical-corporation-fladistctapp-2016.